Global Contract Manufacturing Market, By Service (Pharmaceutical Manufacturing Services, Biologics Manufacturing Services and Drug Development Services), Type (Active Pharmaceutical Ingredients (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing and Secondary Packaging), End User (Big Pharmaceuticals, Small and Mid-Size Pharmaceuticals, Generic Pharmaceutical Companies and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Data Bridge Market Research analyses that the contract manufacturing market will exhibit a CAGR of around 6.45% for the forecast period of 2021-2028. Rising prevalence of cardiovascular diseases, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of contract manufacturing market.
Under contract manufacturing, the firms provide services such as production of goods by firm, under the label or brand of another firm. In other words, contract manufacturing is managing of one company’s resources by the other company to manufacture its products.
Upsurge in the prevalence of oncological diseases globally is one of the major factors fostering the growth of the market. Rising focus on the healthcare technological advancements coupled with ever-rising geriatric population is another market growth determinant. Rising research and development proficiencies, growing outsourcing by the major pharmaceutical companies and increasing personal disposable income will further generate lucrative market growth opportunities.
However, high costs associated with logistics will derail the market growth rate. Rising capacity concerns especially in the developing and underdeveloped economies will further pose challenges for the market. Also, stringent regulations on product approvals will also hamper the market growth rate.
This contract manufacturing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on contract manufacturing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Contract Manufacturing Market Scope and Market Size
The contract manufacturing market is segmented on the basis of service, type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on service, contract manufacturing market is segmented into pharmaceutical manufacturing services, biologics manufacturing services and drug development services. Pharmaceutical manufacturing services segment is sub-segmented into pharmaceutical API manufacturing services and pharmaceutical FDF manufacturing services. Biologics manufacturing services segment is sub-segmented into biologics FDF manufacturing services and biologics API manufacturing services.
- The type segment of the contract manufacturing market is segmented into active pharmaceutical ingredients (API) manufacturing, finished dosage formulation (FDF) development and manufacturing and secondary packaging.
- The contract manufacturing market has also been segmented based on the end user into big pharmaceuticals, small and mid-size pharmaceuticals, generic pharmaceutical companies and others.
Contract Manufacturing Market Country Level Analysis
The contract manufacturing market is analysed and market size insights and trends are provided by country, service, type and end user as referenced above.
The countries covered in the contract manufacturing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the contract manufacturing market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the prevailing advanced healthcare technologies, growing demand for generic drugs and prevalence of patient specific health care systems. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the growth and expansion of healthcare industry in this region, availability of low cost skilled workforce and growing prevalence of cardiovascular disorders.
The country section of the contract manufacturing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare infrastructure growth installed base and new technology penetration
The contract manufacturing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for contract manufacturing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the contract manufacturing market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Contract Manufacturing Market Share Analysis
The contract manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to contract manufacturing market.
The major players covered in the contract manufacturing market report are Baxter., Thermo Fisher Scientific Inc., Lonza, Recipharm AB (publ)., Jubilant Pharmova Limited, Catalent, Inc, Vetter Pharma-Fertigung GmbH & Co. KG, Abbvie Inc., FAMAR Health Care Services, Aenova Holding GmbH, Consort Medical plc, Pfizer Inc., Almac Group, Siegfried Holding AG, Boehringer Ingelheim International GmbH , Evonik Industries AG, Avid Bioservices, Inc., Merck & Co., Inc, Dr. Reddy’s Laboratories Ltd and Sun Pharmaceutical Industries Ltd. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Contract Manufacturing Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.